Danielle Perry

Apr 16, 2024 | cfp.ca | Danielle Perry |G. Michael Allan

Clinical questionHow effective and safe is respiratory syncytial virus (RSV) vaccination in older adults? Bottom lineFor roughly every 380 medically stable patients (≥60 years), RSV vaccination prevents 1 RSV-associated lower respiratory tract disease (LRTD) per season (vs placebo). Fatigue occurs in 34% of patients (vs 16% placebo). Guidance suggests administering based on shared decision making, mainly in those at higher risk. EvidenceResults were statistically different unless indicated.

Apr 16, 2024 | cfp.ca | Betsy Thomas |Danielle Perry |Samantha Moe |Ricky Turgeon

Main messageHow does prescribing a high-dose statin compare to a “treat-to-target” strategy in patients with coronary artery disease?